At meeting held on 26 April 2017
Sword & Shield Pharma announced that the Board of Directors at its meeting held on 26 April 2017, has proposed the Amalgamation in the nature of Merger of Praveg Communications ("the Transferor Company" or "PCL") with Sword & Shield Pharma ("the Transferee Company" or "SSPL" or "the Company"), under Sections 230 to 232 of the Companies Act, 2013 and other applicable laws including the provisions of the Companies Act, 1956 to the extent applicable with the appointed date i.e. 01 April 2016. The same is subject to the approval of the Shareholders, the National Company Law Tribunal, Ahmedabad (NCLT) and all the other regulatory approvals.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app